SOPHARMA AD - Conclusion of a transaction under the application of Article 114, paragraph 2 of the LPOS

Spis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załączników:

1. SFA_01072025_SFI_114_EN_espi.pdfConclusion of a transaction under the application of Article 114, paragraph 2 of the LPOS
   

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No 78 / 2025

Date of issue: 2025-07-01

Short name of the issuer

SOPHARMA AD

Subject

Conclusion of a transaction under the application of Article 114, paragraph 2 of the LPOS

Official market - legal basis

art. 56. 1. 2 of Act on Public Offering.

Unofficial market - legal basis

Contents of the report:

Conclusion of a transaction under the application of Article 114, paragraph 2 of the LPOS

Annexes

File Description

SFA_01072025_SFI_114_EN_espi.pdfSFA_01072025_SFI_114_EN_espi.pdf Conclusion of a transaction under the application of Article 114, paragraph 2 of the LPOS

SOPHARMA AD

(fullname of the issuer)

SOPHARMA AD Farmaceutyczny (far)

(short name of the issuer) (sector according to clasification of the WSE in Warsow)

1220 Sofia

(post code) (city)

IlienskoShosse 16

(street) (number)

[phone] [phone]

(phone number) (fax)

(e-mail) (web site)

nd

(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Date Name Position / Function Signature

Ognian Donev Executive Director